- Home
- Products
- Hematology Test
- Clinical Chemistry and Clinical Toxicology
- Mass Spectrometry Testing
- Continuous Glucose Monitoring （CGM）
Diagnosis of cardiovascular disease often requires a combination of clinical examinations and laboratory tests that utilize biomarkers to assess cardiac function and damage. Alta DiagnoTech provides in vitro diagnostic (IVD) kits, reagents, and devices to detect specific markers in specific blood and other samples, which in turn effectively aid in the diagnosis and management of cardiovascular disease in support of precision medicine and personalized treatment plans.
Cardiovascular diseases are diseases that affect the heart and blood vessels, and common types include coronary heart disease, peripheral artery disease, and heart attack. These diseases can lead to serious health problems and even life-threatening conditions. Currently, in the medical field, there are various methods for the detection and diagnosis of cardiovascular diseases, such as electrocardiogram testing, blood biomarker analysis, imaging, and IVD-based analysis at the molecular level. Among them, IVD plays a key role in early detection, risk assessment, and treatment monitoring of cardiovascular diseases. By analyzing biomarkers in body fluids, IVD helps physicians diagnose and manage these diseases more accurately.
Fig.1 Schematic diagram of cardiovascular diseases and their detection methods. (Pang, et al., 2024)
The cardiovascular disease diagnostics market is growing at a rapid pace and is expected to grow at a compound annual growth rate (CAGR) of 7.9% during the period 2021-2026. According to estimates, by 2027, the global cardiovascular disease diagnostics market is projected to reach a market value of approximately $35.2 billion. Cardiovascular diseases continue to be the leading cause of death globally, with a particularly significant impact in low- and middle-income countries, with more than 13 million deaths annually, 85% of which are related to heart disease and stroke. This phenomenon has led to an increase in the demand for cardiac diagnostics, driving the market. Rapid and portable blood and enzyme tests have become the focal point of innovation in the market and are likely to dominate the market in the coming years, providing more flexible and immediate solutions for cardiovascular disease diagnosis.
IVD of cardiovascular disease relies heavily on specially designed diagnostic kits and devices that analyze biomarkers in blood or other samples through in vitro assays, enabling physicians to accurately detect and assess cardiovascular health. Below are some of the products used for IVD for cardiovascular disease:
| Products | Detection Methods | Target Disease |
| Core Marker Assay Kit | ELISA | Myocardial infarction disease |
| Multiple Cardiac Enzyme Analyzer | Chemiluminescent immunoassay | Myocardial injury disease |
| B-type Natriuretic Peptide (BNP) Kit | Immunoturbidimetric assay | Heart failure disease |
| Gene Sequencing Cardiac Risk Assessment Reagent | Gene sequencing | Congenital heart disease |
With advanced technology and rich experience in clinical diagnostics and IVD, Alta DiagnoTech helps clients achieve rapid and accurate screening and diagnosis of cardiovascular diseases through the provision of products for IVD cardiovascular diseases, thus improving patients' treatment outcomes and quality of life.
Relying on precise molecular diagnostics and innovative IVD products, Alta DiagnoTech opens new channels in the field of cardiovascular disease detection, helping healthcare organizations improve diagnostic capabilities and optimize patient management. Please feel free to contact us if you are interested in our IVD products.
Reference
|
There is no product in your cart. |
Copyright © Alta DiagenoTech. All rights reserved.
